Launched in 2009, the Ophthalmology Innovation Summit serves to showcase ... an exchange of information and connections to drive innovation in the retina, anterior segment, and optometry. About ...

Ophthalmology Times connects eye care professionals with surgery, imaging, gene therapy, & diagnostic advances to enhance ...

Viatris's phase 3 trial for pimecrolimus 0.3% in blepharitis failed to meet its primary endpoint of debris resolution after ...

A 64-year-old woman presented to an outside provider with 5 days of left eye “burning, itching, redness and blurry vision” ...

VTRS slides after phase III trial failure for blepharitis drug MR-139, adding pressure to an already struggling stock.

Clearside’s innovative SCS Microinjector is being used in commercial ophthalmic products and promising clinical development programs by Aura Biosciences, Bausch + Lomb, BioCryst Pharmaceuticals, ...

Boy, I know that there are some really terrible jobs in the extended health care universe, but it sure seems like one of them ...

Identifying the correct uveitis type can help reveal underlying systemic infections, neoplastic conditions, and other ...

Within the treated group, eyes with plus disease had consistently lower C/D values than those without plus disease, a finding the study authors say may result from obscuring of the optic cup by ...

Cloudbreak Pharma Inc. a clinical-stage ophthalmology company developing innovative therapies for ocular surface diseases, ...

Discover the latest headlines on Donald Trump, including coverage of his second presidency, trade and tariff policies, legal developments and more.